FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1625351617> ?p ?o ?g. }

• W1625351617 abstract "Non-Hodgkin9s lymphoma includes mostly mature B cell lymphomas such as Burkitt lymphoma (BL), diffuse large cell lymphoma (DLBCL), and follicular lymphoma which are all derived from germinal center B (GCB) cells. Clarifying the molecular mechanisms during lymphomagenesis requires appropriate mouse models with short latency that can be easy to monitor the whole process from the cell of origin to full-blown lymphoma. Here, we developed a novel mouse model for mature B cell lymphoma originated from GCB cells by using ex vivo culture system with retroviral transduction. Naive B cells harvested from Ink4a/Arf-/- mice were cultured and stimulated with IL-4 and anti-CD40 antibody to differentiate into GCB cells. GCB cells were retrovirally transduced with c-Myc, highly expressed in most human lymphomas, and then transplanted into irradiated mice. Around 60% of mice transplanted via intraperitoneal injection exhibited splenomegaly and enlarged lymph nodes in the axilla, inguinal and intestinal regions, and finally died. Lymphoma cells and tissues from those mice showed mature B cell immunophenope (B220+IgM+IgD+) and histopathology similar to human Burkitt lymphoma. Interestingly, lymphoma cells from all analyzed mice did not show Fas expression at protein and mRNA levels in contrast to the original GCB cells that highly express Fas. Furthermore, spontaneously developed lymphoma cells in all λ-Myc mice (a transgenic mouse carrying c-Myc under the control of the Igλ light chain enhancer) also showed no Fas expression. Fas is a cell death receptor which has an important role in negative selection of GCB cells with high affinity antibody. To clarify the role of Fas downregulation in lymphomagenesis, Ink4a/Arf-/- GCB cells were transduced with c-Myc and shRNA for Fas and then transplanted. All mice transplanted with shFas-treated GCB cells developed lymphoma and died faster than mice transplanted with shControl-treated GCB cells. These results suggest that Fas downregulation is required for lymphomagenesis. In primary culture of the lymphoma cells, Fas expression was restored after CD40 ligand treatments, suggesting that reduced CD40 signaling may be involved in Fas downregulation. We further found that 8 out of 10 human lymphoma cell lines including 2 BL and 6 DLBCL exhibited low Fas expression whereas 2 cell lines exhibited high Fas expression. Among those Fas-downregulated cells, Fas expression in some cell lines was restored not only after Fas ligand treatment, but also after a DNA methyltransferase inhibitor 5-Aza-dC treatment or an HDAC inhibitor TSA treatment, indicating that Fas expression is also regulated by epigenetic mechanisms in human lymphoma cells. Collectively, these findings suggest that Fas downregulation is a crucial event for mature B cell lymphomagenesis to escape from immune surveillance and that restoration of Fas expression could be a new strategy for lymphoma treatment. Citation Format: Eiji Sugihara, Norisato Hashimoto, Sayaka Ueno, Hideyuki Saya. Novel mouse model for mature B cell lymphoma reveals the requirement of Fas downregulation in lymphomagenesis. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2283. doi:10.1158/1538-7445.AM2015-2283" @default.
• W1625351617 created "2016-06-24" @default.
• W1625351617 creator A5014020819 @default.
• W1625351617 creator A5039137137 @default.
• W1625351617 creator A5040541747 @default.
• W1625351617 creator A5071189402 @default.
• W1625351617 date "2015-08-01" @default.
• W1625351617 modified "2023-09-26" @default.
• W1625351617 title "Abstract 2283: Novel mouse model for mature B cell lymphoma reveals the requirement of Fas downregulation in lymphomagenesis" @default.
• W1625351617 doi "https://doi.org/10.1158/1538-7445.am2015-2283" @default.
• W1625351617 hasPublicationYear "2015" @default.
• W1625351617 type Work @default.
• W1625351617 sameAs 1625351617 @default.
• W1625351617 citedByCount "0" @default.
• W1625351617 crossrefType "proceedings-article" @default.
• W1625351617 hasAuthorship W1625351617A5014020819 @default.
• W1625351617 hasAuthorship W1625351617A5039137137 @default.
• W1625351617 hasAuthorship W1625351617A5040541747 @default.
• W1625351617 hasAuthorship W1625351617A5071189402 @default.
• W1625351617 hasConcept C142724271 @default.
• W1625351617 hasConcept C154317977 @default.
• W1625351617 hasConcept C159654299 @default.
• W1625351617 hasConcept C202751555 @default.
• W1625351617 hasConcept C203014093 @default.
• W1625351617 hasConcept C2777257650 @default.
• W1625351617 hasConcept C2778453870 @default.
• W1625351617 hasConcept C2779338263 @default.
• W1625351617 hasConcept C39347974 @default.
• W1625351617 hasConcept C502942594 @default.
• W1625351617 hasConcept C55493867 @default.
• W1625351617 hasConcept C71924100 @default.
• W1625351617 hasConcept C86803240 @default.
• W1625351617 hasConcept C96926380 @default.
• W1625351617 hasConceptScore W1625351617C142724271 @default.
• W1625351617 hasConceptScore W1625351617C154317977 @default.
• W1625351617 hasConceptScore W1625351617C159654299 @default.
• W1625351617 hasConceptScore W1625351617C202751555 @default.
• W1625351617 hasConceptScore W1625351617C203014093 @default.
• W1625351617 hasConceptScore W1625351617C2777257650 @default.
• W1625351617 hasConceptScore W1625351617C2778453870 @default.
• W1625351617 hasConceptScore W1625351617C2779338263 @default.
• W1625351617 hasConceptScore W1625351617C39347974 @default.
• W1625351617 hasConceptScore W1625351617C502942594 @default.
• W1625351617 hasConceptScore W1625351617C55493867 @default.
• W1625351617 hasConceptScore W1625351617C71924100 @default.
• W1625351617 hasConceptScore W1625351617C86803240 @default.
• W1625351617 hasConceptScore W1625351617C96926380 @default.
• W1625351617 hasLocation W16253516171 @default.
• W1625351617 hasOpenAccess W1625351617 @default.
• W1625351617 hasPrimaryLocation W16253516171 @default.
• W1625351617 hasRelatedWork W1971012850 @default.
• W1625351617 hasRelatedWork W2002524026 @default.
• W1625351617 hasRelatedWork W2059871989 @default.
• W1625351617 hasRelatedWork W2156834005 @default.
• W1625351617 hasRelatedWork W2243979166 @default.
• W1625351617 hasRelatedWork W2276743179 @default.
• W1625351617 hasRelatedWork W2485420900 @default.
• W1625351617 hasRelatedWork W2550754673 @default.
• W1625351617 hasRelatedWork W2555524918 @default.
• W1625351617 hasRelatedWork W2556203902 @default.
• W1625351617 hasRelatedWork W2557717703 @default.
• W1625351617 hasRelatedWork W2563463887 @default.
• W1625351617 hasRelatedWork W2940720857 @default.
• W1625351617 hasRelatedWork W2953795647 @default.
• W1625351617 hasRelatedWork W2978738458 @default.
• W1625351617 hasRelatedWork W2986993174 @default.
• W1625351617 hasRelatedWork W2992169862 @default.
• W1625351617 hasRelatedWork W2999214870 @default.
• W1625351617 hasRelatedWork W3037395720 @default.
• W1625351617 hasRelatedWork W3164555343 @default.
• W1625351617 isParatext "false" @default.
• W1625351617 isRetracted "false" @default.
• W1625351617 magId "1625351617" @default.
• W1625351617 workType "article" @default.